Trevena
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
955 Chesterbrook Blvd Ste 110, Chesterbr...Phone Number
(610) 354-8840Website
www.trevena.comRevenue
<$5 MillionStock Symbol
TRVNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Trevena
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company's novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.Explore more
Trevena Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trevena your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Trevena had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Trevena
Check if Trevena has recently received funding, and reach out quickly before it becomes old news!
Trevena, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Trevena has new funding data
Product Launch: Get notified when Trevena launches new products
Check out if Trevena is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Trevena recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Trevena as Masked Content
Find more new buyers
Compare Similar Companies to Trevena
Compare insights from companies similar to Trevena, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Trevena is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trevena is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trevena.
Trevena financials insights
Gather financial insights about Trevena, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$64.8M
2022
Other Financing Round
$40M
2023
Share Placement
$4M
2024
Debt
$2M
Trevena Tech Stack
A closer look at the technologies used by Trevena
Most Recent Scoops
Facilities Relocation / Expansion
Trevena is planning to move offices in August 2025. The move will impact approximately 50 employees at the existing office located at 1018 West 8Th Avenue, Suite A, King Of Prussia, PA.
Facilities Relocation/Expansion
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trevena
Sign Up For FreeTo access detailed company insights
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analge... Read More
